Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma Article

cited authors

  • Toomey, Paul; Teta, Anthony; Patel, Krishen; Downs, Darrell; Luberice, Kenneth; Ross, Sharona; Rosemurgy, Alexander S.

Publication Date

  • April 1, 2017

webpage

category

keywords

  • Diabetes
  • Metformin
  • Pancreatic adenocarcinoma
  • Pancreaticoduodenectomy
  • Sulfonylureas

volume

  • 2

issue

  • 3